PAPA JOSEPH C

CIK 000124221510 companiesALLEGAN, MI

SEC Profile

Transactions

Companies

Filings

CIK

0001242215

Recent Transactions

50 trades

Award
Milestone Pharmaceuticals Inc.$MIST
Common Shares
2025-07-11+100,000→ 100,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Series B Common Warrants (right to buy)
2025-07-11+100,000→ 100,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Series A Common Warrants (right to buy)
2025-07-11+100,000→ 100,000 total
Award
Candel Therapeutics, Inc.$CADL
Common Stock
2025-06-25$4.67/sh+64,239→ 64,239 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-06-17+14,240→ 14,240 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2025-06-10+40,000→ 40,000 total
Purchase
Emergent BioSolutions Inc.$EBS
Common Stock
2025-05-13$5.83/sh+60,000→ 342,500 total
Award
Emergent BioSolutions Inc.$EBS
Employee Stock Options (Right to Buy)
2025-03-12+250,000→ 1,282,500 total
Award
Emergent BioSolutions Inc.$EBS
Employee Stock Options (Right to Buy)
2025-03-12+250,000→ 1,532,500 total
Award
Emergent BioSolutions Inc.$EBS
Common Stock
2025-03-06+282,500→ 282,500 total
Award
Emergent BioSolutions Inc.$EBS
Employee Stock Options (Right to Buy)
2025-03-06+282,500→ 1,032,500 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2024-09-03+80,000→ 80,000 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2024-06-26+14,240→ 14,240 total
Award
Emergent BioSolutions Inc.$EBS
Employee Stock Options (Right to Buy)
2024-03-13+750,000→ 750,000 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-06-28+14,240→ 14,240 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−2,165→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−22,551→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Common Stock
2023-06-16−10,000→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−15,000→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−27,340→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−22,652→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Common Stock
2023-06-16−7,278→ 0 total
Other
Prometheus Biosciences, Inc.
Common Stock
2023-06-02−10,000→ 7,278 total
Other
Prometheus Biosciences, Inc.
Common Stock
2023-06-02+10,000→ 10,000 total
Award
Prometheus Biosciences, Inc.
Common Stock
2023-05-19+2,278→ 17,278 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-09$1.94/sh+35,018→ 38,032 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-08$1.70/sh+3,014→ 3,014 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-08-08+28,480→ 28,480 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2022-05-19+22,551→ 22,551 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10$9.40/sh−183,522→ 0 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10$9.40/sh−65,911→ 0 total
Award
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10+116,697→ 0 total
Award
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10+183,522→ 0 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-05-10+116,697→ 1,211,849 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-05-10+183,522→ 1,395,371 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10$9.40/sh−116,697→ 0 total
Award
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-05-10+65,911→ 0 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-05-10+65,911→ 1,461,282 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-05-10$9.40/sh−33,714→ 1,427,568 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2022-05-05+472,222→ 472,222 total
Award
Bausch & Lomb Corp$BLCO
Non-Qualified Stock Options (right to purchase)
2022-05-05+1,868,131→ 1,868,131 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-03-03$23.61/sh−12,643→ 1,095,152 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-02-28$24.06/sh−5,115→ 1,107,795 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-02-27$24.35/sh−208,231→ 0 total
Award
Bausch Health Companies Inc.$BHC
Restricted Share Units
2022-02-27+208,231→ 0 total
Exercise/Conversion
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-02-27+208,231→ 1,239,650 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-02-27$24.35/sh−13,206→ 1,112,910 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-02-27$24.35/sh−100,351→ 1,139,299 total
Tax Payment
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2022-02-26$24.35/sh−13,183→ 1,126,116 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2021-11-14+2,165→ 2,165 total

Companies

Recent Filings

Address

C/O PERRIGO COMPANY 515 EASTERN AVENUE

ALLEGAN, MI, 49010

View on SEC.gov